United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 3,182,700 | 2,877,400 | 2,327,500 | 1,936,300 | 1,685,500 |
| Cost of Goods | 384,400 | 309,700 | 257,500 | 151,600 | 122,500 |
| Gross Profit | 2,798,300 | 2,567,700 | 2,070,000 | 1,784,700 | 1,563,000 |
| Operating Expenses | 1,306,200 | 1,191,400 | 885,600 | 805,600 | 1,007,600 |
| Operating Income | 1,492,500 | 1,377,000 | 1,184,900 | 979,700 | 555,900 |
| Interest Expense | 19,500 | 42,900 | 59,300 | 32,400 | 18,600 |
| Other Income | 240,900 | 204,900 | 148,700 | 3,300 | 56,600 |
| Pre-tax Income | 1,713,900 | 1,539,000 | 1,274,300 | 950,600 | 593,900 |
| Income Tax | 379,200 | 343,900 | 289,500 | 223,300 | 118,100 |
| Net Income Continuous | 1,334,700 | 1,195,100 | 984,800 | 727,300 | 475,800 |
| Net Income | $1,334,700 | $1,195,100 | $984,800 | $727,300 | $475,800 |
| EPS Basic Total Ops | 30.13 | 26.44 | 21.04 | 15.98 | 10.60 |
| EPS Basic Continuous Ops | 30.13 | 26.44 | 21.04 | 15.98 | 10.60 |
| EPS Diluted Total Ops | 27.86 | 24.64 | 19.81 | 15.00 | 10.06 |
| EPS Diluted Continuous Ops | 27.86 | 24.64 | 19.81 | 15.00 | 10.06 |
| EPS Diluted Before Non-Recurring Items | N/A | 24.64 | 19.81 | 15.00 | 10.06 |
| EBITDA(a) | $1,578,100 | $1,449,500 | $1,238,100 | $1,031,000 | $605,800 |